Drew retweetledi

BREAKING:
Several peptides previously flagged under FDA compounding restrictions have reportedly been removed from the Category 2 concern list, including BPC-157, TB-500, GHK-Cu, Semax, MOTS-c, and others.
They still are not FDA approved drugs, but the regulatory landscape around compounding may be shifting again.
Prepare to pay $3000 / month for Semax
English











